about
Intracellular ion channels and cancerElectrophysiology clarifies the megariddles of the mitochondrial permeability transition pore.Mitochondrially targeted anti-cancer agents.Mitochondrial effects of plant-made compounds.Resveratrol and health: the starting point.Prodrugs of quercetin and resveratrol: a strategy under development.Improving the efficacy of plant polyphenols.Synthesis and testing of novel isomeric mitochondriotropic derivatives of resveratrol and quercetin.Cytotoxicity of mitochondria-targeted resveratrol derivatives: interactions with respiratory chain complexes and ATP synthase.An investigation of the occurrence and properties of the mitochondrial intermediate-conductance Ca2+-activated K+ channel mtKCa3.1.Heterogeneity and standardization of phase II metabolism in cultured cells.A mitochondriotropic derivative of quercetin: a strategy to increase the effectiveness of polyphenols.Ester-based precursors to increase the bioavailability of quercetin.Amino Acid Carbamates As Prodrugs Of Resveratrol.Determination of quercetin and resveratrol in whole blood--implications for bioavailability studies.Regioselective O-derivatization of quercetin via ester intermediates. An improved synthesis of rhamnetin and development of a new mitochondriotropic derivative.3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis.Absorption and metabolism of resveratrol carboxyesters and methanesulfonate by explanted rat intestinal segments.Soluble polyphenols: synthesis and bioavailability of 3,4',5-tri(alpha-D-glucose-3-O-succinyl) resveratrol.Impact of mitochondriotropic quercetin derivatives on mitochondria.Quercetin can act either as an inhibitor or an inducer of the mitochondrial permeability transition pore: A demonstration of the ambivalent redox character of polyphenols.Development of mitochondria-targeted derivatives of resveratrol.Synthesis and Evaluation as Prodrugs of Hydrophilic Carbamate Ester Analogues of Resveratrol.Pharmacokinetics and tissue distribution of pterostilbene in the rat.Mitochondria-targeted resveratrol derivatives act as cytotoxic pro-oxidants.N-Monosubstituted Methoxy-oligo(ethylene glycol) Carbamate Ester Prodrugs of ResveratrolA Preliminary Fastview of Mitochondrial Protein Profile from Healthy and Type 2 Diabetic SubjectsNew Water-Soluble Carbamate Ester Derivatives of ResveratrolTargets and Strategies for the Mitochondrial Assault on CancerAcetal Derivatives as Prodrugs of ResveratrolQuercetin Mitochondriotropic Derivatives Antagonize Nitrate Tolerance and Endothelial Dysfunction of Isolated Rat Aorta RingsCytotoxicity of a mitochondriotropic quercetin derivative: MechanismsCorrigendum to “Mitochondrially targeted anti-cancer agents” [Mitochondrion 10 (2010) 670–681]Redox Properties and Cytotoxicity of Synthetic Isomeric Mitochondriotropic Derivatives of the Natural Polyphenol Quercetin
P50
Q27008995-11D5BE43-D7DD-4507-BA71-8FB693F68A4BQ37676566-36DC8643-0B25-4DCB-BB34-F9CC6B3FCDFDQ37769939-38013447-018A-4795-915F-418A2915A7FFQ37873459-73C027F8-822D-436D-9619-0BF35A0CDC0CQ38009762-467E6931-B774-4B66-8EF6-3F368434E605Q38170445-1C2C0265-DE26-43A8-B4F9-BD53C7610AA2Q38224199-194E2E30-8F2D-4BEA-B94F-79D19D81DB6FQ38915142-1D0D5C8B-FF45-47A2-A8A8-81E5590A4D81Q38977812-173A5271-C2F1-4E42-A832-1F2BED1C7F17Q39758627-8CE7E3B0-2E4C-4125-A726-C8064E8B04CEQ39846833-297B5EBF-9928-470C-9127-418EE396666BQ39932213-1ED69679-1A6C-4C43-BA0C-71031FE76765Q40182437-35755CA7-E278-4093-9755-70D943557914Q42592297-EE1F1E0C-C734-4627-9002-97FDC4B95AB7Q42874495-6AEEAA4E-81AE-4787-82BE-CD04C5A18716Q42958867-F2506847-5DC1-454A-80CC-23572A16648BQ43230282-C38A74B5-B6CA-407F-B166-7C4F95C28C5FQ43243107-E5BAF0CA-1053-4DF9-8835-A6B38B0EBDF0Q43257309-8855E2F4-C242-409C-8456-5C712993E232Q43260053-4D9ED9AA-6CF0-4D28-82DC-BC62BB27284EQ45970615-869E3D36-8E1D-4CE6-A255-46BEB4BE3F41Q46341402-B49BCF86-B70B-49B8-AD8F-E328C4E8C398Q46687732-9190B74D-3304-44D3-BFD5-5A4E956AD4AFQ46863513-7455A927-1D66-4370-98D8-96F20B185895Q50967122-8CD23F48-04C4-4CCC-99A9-47DC65D65676Q57974082-D4E0B7E2-A69E-47CD-902F-12844A080A7EQ57974100-D1C9090E-70D8-4C49-BCA6-376754C6A6FBQ57974104-F65394FB-4C0D-404D-828C-F9286CFB4A78Q57974107-53705E87-02FC-4C1D-9A99-AEE0E3C949E5Q57974109-3C6C68A7-69EC-4F33-8387-4B6B15E7F6B3Q57974113-F7653050-916C-4A81-AF7D-AEBD9A740719Q57974118-F0596E1F-D81E-4092-9B55-417A1681EAC8Q57974124-7F09C13F-6698-4620-89BC-841A93D289FDQ57974127-69A4964C-CEE0-4D66-8448-F9E872414EA5
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Lucia Biasutto
@ast
Lucia Biasutto
@en
Lucia Biasutto
@es
Lucia Biasutto
@nl
Lucia Biasutto
@sl
type
label
Lucia Biasutto
@ast
Lucia Biasutto
@en
Lucia Biasutto
@es
Lucia Biasutto
@nl
Lucia Biasutto
@sl
prefLabel
Lucia Biasutto
@ast
Lucia Biasutto
@en
Lucia Biasutto
@es
Lucia Biasutto
@nl
Lucia Biasutto
@sl
P214
P106
P1153
15829089100
P21
P214
P31
P396
IT\ICCU\CFIV\270195
P496
0000-0002-7638-6865
P569
1980-01-01T00:00:00Z
P735
P7859
viaf-307343029